These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 7903241)

  • 1. The Ischaemic Heart: Beta-Blockade or Calcium Channel Blockade? Proceedings of a satellite symposium at the XIVth Congress of the European Society of Cardiology. Barcelona, Spain, 2 September 1992.
    Eur Heart J; 1993 Oct; 14 Suppl F():1-34. PubMed ID: 7903241
    [No Abstract]   [Full Text] [Related]  

  • 2. Hotline sessions at the 20th European Congress of Cardiology.
    Verheugt FW
    Eur Heart J; 1999 Jan; 20(1):7-10. PubMed ID: 10075136
    [No Abstract]   [Full Text] [Related]  

  • 3. Calcium channel antagonists prevent cardiovascular events in Japanese patients with myocardial infarction even in the absence of coronary artery spasm.
    Sakamoto T; Nakao K; Ogawa H
    Circ J; 2011; 75(7):1577-8. PubMed ID: 21617324
    [No Abstract]   [Full Text] [Related]  

  • 4. New aspects of calcium antagonism in cardiovascular disease. Proceedings of a symposium. An official satellite to the Twelfth Congress of the European Society of Cardiology. Stockholm, Sweden, September 19, 1990.
    Am Heart J; 1991 Jul; 122(1 Pt 2):307-74. PubMed ID: 1675838
    [No Abstract]   [Full Text] [Related]  

  • 5. [Silent myocardial ischemia].
    Chen Z
    Zhonghua Xin Xue Guan Bing Za Zhi; 1992 Apr; 20(2):76. PubMed ID: 1361908
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of chronic intercurrent medication with beta-adrenoceptor blockade or calcium channel entry blockade on postoperative silent myocardial ischaemia.
    Sear JW; Foex P; Howell SJ
    Br J Anaesth; 2000 Mar; 84(3):311-5. PubMed ID: 10793588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drugs acting on the heart in therapy of silent myocardial ischemia].
    Motz W; Scheler S; Strauer BE
    Internist (Berl); 1992 Oct; 33(10):695-700. PubMed ID: 1358855
    [No Abstract]   [Full Text] [Related]  

  • 8. [Left ventricular diastolic dysfunction in ischemic heart disease. Effects of drug therapy].
    Witkowska M
    Kardiol Pol; 1992 Dec; 37(12):399-403. PubMed ID: 1363437
    [No Abstract]   [Full Text] [Related]  

  • 9. [Silent myocardial ischemia and its combined therapy of traditional Chinese and Western medicine].
    Li J
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1992 Sep; 12(9):548-50. PubMed ID: 1363692
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevention and therapy of perioperative myocardial ischemia].
    Bardenheuer HJ; Martin E
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1995 May; 30(3):133-5. PubMed ID: 7605831
    [No Abstract]   [Full Text] [Related]  

  • 11. [Heart rate control: f-channel blockers].
    Kryzhanovskiĭ SA; Vititnova MB
    Fiziol Cheloveka; 2009; 35(2):112-23. PubMed ID: 19402561
    [No Abstract]   [Full Text] [Related]  

  • 12. [Medical treatment for silent myocardial ischemia: comparison of nitrate, calcium antagonist, and beta-blocker].
    Tomita F; Kohya T; Kitabatake A
    Nihon Rinsho; 1994 Aug; 52 Suppl(Pt 2):516-22. PubMed ID: 12440020
    [No Abstract]   [Full Text] [Related]  

  • 13. [The anesthesiological risk and treatment characteristics of patients with ischemic heart disease prepared preoperatively with beta-receptor blockers, calcium antagonists and nitro preparations].
    Gruev L; Khinev S; Tikhchev T; Bochev D; Dafinova K; Pelov R; Cherkezov Zh
    Khirurgiia (Sofiia); 1993; 46(5):53-5. PubMed ID: 7983827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic application of myocardial cytoprotection].
    Ribeiro C
    Rev Port Cardiol; 1994 Sep; 13(9):669-70. PubMed ID: 7818940
    [No Abstract]   [Full Text] [Related]  

  • 15. New aspects of the treatment of ischemic heath disease with calcium antagonists. Proceedings of the International Nisoldipine Symposium. Düsseldorf, Germany, March 27-29, 1992.
    J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S1-81. PubMed ID: 1282607
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lipid peroxidation and antioxidant defense system in myocardial ischemia].
    Barsel' VA; Syrkin AL; Eliubaeva ID; Kogan IG; Vakhliaev VD; Aksiutina MS; Arkhipova TV; Shchedrina IS
    Dokl Akad Nauk; 1996 Dec; 351(5):706-8. PubMed ID: 9102090
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drugs used in cardiovascular diseases and cytokines].
    Andrzejczak D; Górska D
    Wiad Lek; 2006; 59(3-4):232-7. PubMed ID: 16813270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Indications for calcium channel antagonist therapy according to the latest large clinical trials].
    Kosicka T; Kara-Perz H; Głuszek J; Perz S
    Pol Arch Med Wewn; 2005 Dec; 114(6):1244-51. PubMed ID: 16789496
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pathogenesis, diagnosis and conservative treatment of ischemic heart disease in patients with chronic renal failure].
    Imiela J
    Pol Arch Med Wewn; 2000 Oct; 104(4):671-9. PubMed ID: 11392155
    [No Abstract]   [Full Text] [Related]  

  • 20. Evolving Issues in the Treatment of Ischaemic Heart Disease: The Potassium Channel Openers. Symposium proceedings. Barcelona, Spain, 2 September 1992.
    Eur Heart J; 1993 Jul; 14 Suppl B():1-52. PubMed ID: 8103740
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.